Rijit bronkoskopide kullanılan mivakuryum ile süksinilkolinin nöromüsküler ve hemodinamik etkiler açısından karşılaştırılması

Amaç: Çalışmamızda rijit bronkoskopilerde süksinilkolin ile yeni bir kısa etkili nondepolarizan kas gevşetici ajan olan mivakuryumu entübasyon kalitesi, etki süresi ve hemodinami açısından karşılaştırmayı amaçladık. Yöntem: Araştırmamız genel anestezi altında rijit bronkoskopi planlanan ASA l-ll, yaşları 18-70 arasında değişen 30 hasta üzerinde yapıldı. Hastalar mivakuryum ve süksinilkolin verilen grup olmak üzere tesadüfi olarak 15'er kişilik iki gruba ayrıldı. Bulgular: Gruplar arasında onset time (OT) ve entübasyon anındaki nöromüsküler blok (EANMB) % açısından önemli fark bulundu. Maksimum nöromüsküler blok (MNMB)% ve entübasyon skoru açısından anlamlı fark bulunmadı. Sonuç: Süksinilkolin ve antikolinesteraziara ait ciddi yan etkiler göz önüne alındığında mivakuryumun kısa cerrahi işlemlerde bir alternatif olduğu sonucuna varıldı.

Comparison of the effects of mivacurium and succinylcholine, used for rigid bronchoscopy, on neuromuscular block and hemodynamics

Aim: in this study, we aimed to compare the effects of mivacurium, is a new short-acting non:depolarizing muscular relaxant, with succinylcholine on neuromuscular block and homodynamic during rigid bronchoscopy. Methods: The study group consisted of thirty adults, ASA physical status l or II; aged 18-70 years and scheduled for rigid bronchoscopy under general anesthesia. Patients were assigned randomly to receive either mivacurium (n=15) or succinylcholine (n=15). Results: There was a significant difference in the onset time (OT) and neuromuscular block during intubation % between two groups. There were no statistically significant differences in maximum neuromuscular block % and intubation score. Conclusion: We concluded that, if severe side effects of succinylcholine or anticholinesterase are considered, mivacurium might be an altemative during short surgical procedures

___

  • Faber LP, Warren WH. Endoscopic examinations. In: Shields TW, ed. General Thoracic Surgery. 3rd ed. Philadelphia. London:Lea & Febiger, 1989;245-59.
  • Goldberg ME, Larijani GE, Azad SS, Sosis M, Seltzer JL, Ascher J, et al. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients. Anesth Analg 1989;69:93-9.
  • Cook DR. Muscle relaxants in infants and children. Anesth Analg 1988;160:335- 43.
  • Lee C. Succinylcholine: Its past, present and future. In: Katz RL, editor. Muscle relaxants: Basic and clinical aspects. Orlando: Grune & Stratton; 1984. p.69- 85.
  • Cade L, Kakulas P. Mivacurium in daycase surgical patients. Anaesth Intens Care 1997;25:133-7.
  • Dodgson MS, Heier T, Steen PA. Atracurium compared with suxamethonium for outpatient laparoscopy. Br J Anaesth 1986;58:40S-43S.
  • Maddineni VR, Mirakhur RK, McCoy EP, et al. Neuromuscular effects and intubating conditions following mivacurium: A comparison with suxamethonium. Anaesthesia 1993;48:940-5.
  • Choi WW, Mehta MP, Murray DJ, Sokol MD, Forbes RD, Gergis SD, et al. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia. Can J Anaesth 1989;36:641-50.
  • Weber S, Brandom BW, Powers DM, Sarner JB, Woelfel SK, Cook DR, et al. Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesth Analg 1988;67:495-9.
  • From RP, Pearson KS, Choi WW, Abou-Donia M, Sokoll MD. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anesthesia. Brit J Anesth 1990;64:193-8.
  • Goldhill DR, Whitehead JP, Emmott RS, Griffitt AP, Bracey BJ, Flynn PJ. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia. Brit J Anesth 1991;67:289-95.
  • Wrigley SR, Jones RM, Harrop-Griffiths AW, Platt MW. Mivacurium chloride: A study to evaluate its use during propofol-nitrous oxide anaesthesia. Anaesthesia 1992;47:653 -7.
  • Mirakhur RK, Ferres CJ, Clarke RSJ, Bali IM, Dundee JW. Clinical evaluation of Org NC45. Brit J Anesth 1983;55:119-24.
  • Mirakhur RK, Lavery GG, Clarke RSJ, Gibson FM, McAteer E. Atracurium in clinical anaesthesia: Effect of dosage on onset, duration and conditions for tracheal intubation. Anaesthesia 1985;40:801-5.
  • Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, et al. Clinical pharmacology of atracurium given in high dose. Brit J Anesth 1986;58:834-8.
  • Gramstad L, Lilleaasen P. Dose-response relation for atracurium, ORG NC 45 and pancuronium. Brit J Anesth 1982;54:647-51.
  • Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. Brit J Anesth 1989;63:393-9.
  • Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P. Clinical pharmacology of ORG NC45. A new non-depolarizing muscle relaxant. Anesthesiol 1981;55:6-11.
  • Cook DR, Stiller RL, Weakley JN, Chakravorti S, Brandom BW, Welch RM. In vitro metabolism of mivacurium chloride and succinylcholine. Anesth Analg 1989;68:452-6.
  • DeBros F, Basta SJ, Ali HH, et al. Pharmacokinetics and pharmacodynamics of BW B1090U in healthy surgical patients receiving N2O/O2 isoflurane anesthesia. Anesthesiol 1987;67:A609.
  • Maddineni VR, Mirakhur RK. Prolonged neuromuscular block following mivacurium. Anesthesiol 1993;78:1181-4.
  • Petersen RS, Bailey PL, Kalameghan R, Ashwood ER. Prolonged neuromuscular block after mivacurium. Anesth Analg 1993;76:194-6.
  • Tang J, Joshi GP, White PF. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery. Anesth Analg 1996;82:994-8.
  • Dubois MY, Lea DE, Kataria B, Gadde PL, Tran OQ, Shearrow T. Pharmacodynamics of rocuronium with and without prior administration of succinylcholine. J Clin Anesth 1995;7:44-8.
  • Magorian T, Flannery KB, Miller RD. Comparison of rocuronium, succinylcholine and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiol 1993;79:913-8.
  • Savarese JJ, Ali HH, Basta SJ, Csott RP, Embree PB, Wastila WB, et al. The cardiovascular effect of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiol 1989;70:386-94.
  • Brandom BW, Woelfel SK, Cook DR, Weber S, Powers DM; Weakly JN. Comparison of mivacurium and suxamethonium administered by bolus and infusion. British Journal of Anesthesia 1989;62:488-93.
  • McPeek JB, Nozik DH, Walzer SG et al. Comparison of BWB1090U with succinylcholine to facilitate endotracheal intubation in an outpatient surgical unit. Anesthesiol 1987;67:A352.
  • King MJ, Milazkiewicz R, Carli F, Deacock AR. Influence of neostigmine on postoperative vomiting. Brit J Anesth 1988;61:403-6.
  • Janhunen L, Tammisto T. Postoperative vomiting after different modes of general anaesthesia. Ann Chir Gynaecol 1972;61:152-9.